Back to Results
First PageMeta Content



Phase 1b Trial of Tarextumab (OMP 59R5) (anti-Notch 2/3 antibody) in Combination with Etoposide and Cisplatin (EP) in Patients (pts) with Untreated Extensive-Stage Small-Cell Lung Cancer (ED-SCLC): PINNACLE Study M Cathe
Add to Reading List

Document Date: 2014-09-25 16:16:58


Open Document

File Size: 460,20 KB

Share Result on Facebook
UPDATE